Low frequency of ceftazidime-avibactam resistance among Enterobacteriaceae isolates carrying blaKPC collected in U.S. hospitals from 2012 to 2015

Antimicrobial Agents and Chemotherapy

Volumn 61, Issue 3, 2017, Pages

  Castanheira, Mariana ^a   Mendes, Rodrigo E ^a   Sader, Helio S ^a  

^a JMI LABORATORIES   (United States)

Author keywords

Ceftazidime avibactam; KPC; Permeability

Indexed keywords

AMIKACIN; AVIBACTAM PLUS CEFTAZIDIME; CARBAPENEM; COLISTIN; METALLO BETA LACTAMASE; PORIN; TIGECYCLINE; ANTIINFECTIVE AGENT; AVIBACTAM, CEFTAZIDIME DRUG COMBINATION; AZABICYCLO DERIVATIVE; BETA LACTAMASE; CEFTAZIDIME; MINOCYCLINE;

ABDOMINAL INFECTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; HOSPITAL; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PNEUMONIA; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION; STOP CODON; UNITED STATES; URINARY TRACT INFECTION; WHOLE GENOME SEQUENCING; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PLASMID; PNEUMONIA, BACTERIAL; SOFT TISSUE INFECTIONS; URINARY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; AZABICYCLO COMPOUNDS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFTAZIDIME; COLISTIN; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENE EXPRESSION; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; PLASMIDS; PNEUMONIA, BACTERIAL; SOFT TISSUE INFECTIONS; UNITED STATES; URINARY TRACT INFECTIONS;

EID: 85014121302     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02369-16     Document Type: Article

References (31)

1. Pitout JD, Nordmann P, Poirel L. 2015. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59:5873-5884. https://doi.org/10.1128/AAC.01019-15.
2. Doi Y, Paterson DL. 2015. Carbapenemase-producing Enterobacteriaceae. Semin Respir Crit Care Med 36:74-84. https://doi.org/10.1055/s-0035-1544208.
3. King DT, King AM, Lal SM, Wright GD, Strynadka NC. 2015. Molecular mechanism of avibactam-mediated beta-lactamase inhibition. ACS Infect Dis 1:175-184. https://doi.org/10.1021/acsinfecdis.5b00007.
4. FDA. 2015. Avycaz® (ceftazidime-avibactam) package insert. http://www.accessdata.fda.gov/drugsatfda-docs/label/2015/206494s000lbl.pdf. Accessed March 2016.
5. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. 2001. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151-1161. https://doi.org/10.1128/AAC.45.4.1151-1161.2001.
6. CDC. 2015. Tracking CRE infections. http://www.cdc.gov/hai/organisms/cre/TrackingCRE.html. Accessed April 2016.
7. Endimiani A, Hujer KM, Hujer AM, Pulse ME, Weiss WJ, Bonomo RA. 2011. Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 55:82-85. https://doi.org/10.1128/AAC.01198-10.
8. Shields RK, Clancy CJ, Hao B, Chen L, Press EG, Iovine NM, Kreiswirth BN, Nguyen MH. 2015. Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum beta-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae. Antimicrob Agents Chemother 59:5793-5797. https://doi.org/10.1128/AAC.00548-15.
9. Vasoo S, Cunningham SA, Cole NC, Kohner PC, Menon SR, Krause KM, Harris KA, De PP, Koh TH, Patel R. 2015. In vitro activities of ceftazidime-avibactam, aztreonam-avibactam, and a panel of older and contemporary antimicrobial agents against carbapenemase-producing Gram-negative bacilli. Antimicrob Agents Chemother 59:7842-7846. https://doi.org/10.1128/AAC.02019-15.
10. KPC into bacterial species beyond Klebsiella pneumoniae and in vitro susceptibility to ceftazidime-avibactam and aztreonam-avibactam. Antimicrob Agents Chemother 60:4490-4500. https://doi.org/10.1128/AAC.00107-16.
11. Humphries RM, Yang S, Hemarajata P, Ward KW, Hindler JA, Miller SA, Gregson A. 2015. First report of ceftazidime-avibactam resistance in a KPC-3-expressing Klebsiella pneumoniae isolate. Antimicrob Agents Chemother 59:6605-6607. https://doi.org/10.1128/AAC.01165-15.
12. Aitken SL, Tarrand JJ, Deshpande LM, Tverdek FP, Jones AL, Shelburne SA, Prince RA, Bhatti MM, Rolston KV, Jones RN, Castanheira M, Chemaly RF. 2016. High rates of nonsusceptibility to ceftazidime-avibactam and identification of New Delhi metallo-beta-lactamase production in Enterobacteriaceae bloodstream infections at a major cancer center. Clin Infect Dis 63:954-958. https://doi.org/10.1093/cid/ciw398.
13. Shields RK, Potoski BA, Haidar G, Hao B, Doi Y, Chen L, Press EG, Kreiswirth BN, Clancy CJ, Nguyen MH. 2016. Clinical outcomes, drug toxicity and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections. Clin Infect Dis 63:1615-1618. https://doi.org/10.1093/cid/ciw636.
14. Castanheira M, Deshpande LM, Mills JC, Jones RN, Soave R, Jenkins SG, Schuetz AN. 2016. Klebsiella pneumoniae from a New York City hospital belonging to ST258 and carrying blaKPC-2- and blaVIM-4-encoding genes. Antimicrob Agents Chemother 60:1924-1927. https://doi.org/10.1128/AAC.01844-15.
15. Domenech-Sanchez A, Hernandez-Alles S, Martinez-Martinez L, Benedi VJ, Alberti S. 1999. Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance. J Bacteriol 181:2726-2732.
16. Alba J, Ishii Y, Thomson K, Moland ES, Yamaguchi K. 2005. Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother 49:4760-4762. https://doi.org/10.1128/AAC.49.11.4760-4762.2005.
17. Winkler ML, Papp-Wallace KM, Bonomo RA. 2015. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV beta-lactamases with single amino acid substitutions in the Omega-loop. J Antimicrob Chemother 70:2279-2286. https://doi.org/10.1093/jac/dkv094.
18. Papp-Wallace KM, Winkler ML, Taracila MA, Bonomo RA. 2015. Variants of the KPC-2 beta-lactamase which are resistant to inhibition by avibactam. Antimicrob Agents Chemother 59:3710-3717. https://doi.org/10.1128/AAC.04406-14.
19. Livermore DM, Warner M, Jamrozy D, Mushtaq S, Nichols WW, Mustafa N, Woodford N. 2015. In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase. Antimicrob Agents Chemother 59:5324-5330. https://doi.org/10.1128/AAC.00678-15.
20. Pages JM, Peslier S, Keating TA, Lavigne JP, Nichols WW. 2016. Role of the outer membrane and porins in susceptibility of beta-lactamase-producing Enterobacteriaceae to ceftazidime-avibactam. Antimicrob Agents Chemother 60:1349-1359. https://doi.org/10.1128/AAC.01585-15.
21. Clinical and Laboratory Standards Institute. 2015. M07-A10. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 10th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
22. Clinical and Laboratory Standards Institute. 2016. M100-S26. Performance standards for antimicrobial susceptibility testing: 26th informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
23. Pfizer. 2015. Tygacil® package insert. http://labeling.pfizer.com/ShowLabeling.aspx?id=491. Accessed August 2015.
24. EUCAST. 2016. Breakpoint tables for interpretation of MICs and zone diameters, version 6.0, January 2016. http://www.eucast.org/clinical-breakpoints/. Accessed January 2016.
25. Castanheira M, Mendes RE, Woosley LN, Jones RN. 2011. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09). J Antimicrob Chemother 66:1409-1411. https://doi.org/10.1093/jac/dkr081.
26. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455-477. https://doi.org/10.1089/cmb.2012.0021.
27. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL. 2009. BLAST+: architecture and applications. BMC Bioinformatics 10:421. https://doi.org/10.1186/1471-2105-10-421.
28. de Man TJ, Limbago BM. 2016. SSTAR, a stand-alone easy-to-use antimicrobial resistance gene predictor. mSphere 1:00050-15. https://doi.org/10.1128/mSphere.00050-15.
29. Gupta SK, Padmanabhan BR, Diene SM, Lopez-Rojas R, Kempf M, Landraud L, Rolain JM. 2014. ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob Agents Chemother 58:212-220. https://doi.org/10.1128/AAC.01310-13.
30. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640-2644. https://doi.org/10.1093/jac/dks261.
31. Castanheira M, Costello SE, Woosley LN, Deshpande LM, Davies TA, Jones RN. 2014. Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, GES-22 and VIM-35. Antimicrob Agents Chemother 58:7358-7366. https://doi.org/10.1128/AAC.03930-14.